SMTL ID : 3g9e.1

Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x RO7: (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid(Non-covalent)

RO7.1: 15 residues within 4Å: Chain A: F.76, G.78, C.79, S.83, H.117, Y.121, L.124, V.133, I.135, F.157, M.158, K.161, H.243, L.263, Y.267 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Y.121, A:L.124, A:V.133 Hydrogen bonds: A:S.83, A:Y.267 Salt bridges: A:H.117, A:H.243

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Benardeau, A. et al., Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-06-02

Peptides

Peroxisome proliferator-activated receptor gamma: A
Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxisome proliferator-activated receptor gamma

Nuclear receptor coactivator 1

Related Entries With Identical Sequence